Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections
Balamurugan Shanmugaraj, Konlavat Siriwattananon, Ashwini Malla, et al.
Pathogens (2021) Vol. 10, Iss. 8, pp. 1051-1051
Open Access | Times Cited: 21

Showing 21 citing articles:

Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity
Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, et al.
Vaccine (2022) Vol. 40, Iss. 32, pp. 4440-4452
Open Access | Times Cited: 31
Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Narach Khorattanakulchai, et al.
Vaccine (2023) Vol. 41, Iss. 17, pp. 2781-2792
Open Access | Times Cited: 13
Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals
Gergana Zahmanova, Alaa A. A. Aljabali, Katerina Takova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17575-17575
Open Access | Times Cited: 12
Transient Expression of Glycosylated SARS-CoV-2 Antigens in Nicotiana benthamiana
Valentina Ruocco, Richard Strasser
Plants (2022) Vol. 11, Iss. 8, pp. 1093-1093
Open Access | Times Cited: 18
Plant-Based Vaccines in Combat against Coronavirus Diseases
Benita Ortega-Berlanga, Tomasz Pniewski
Vaccines (2022) Vol. 10, Iss. 2, pp. 138-138
Open Access | Times Cited: 16
Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern
Narach Khorattanakulchai, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4265-4276
Open Access | Times Cited: 16
COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks
Chandran Murugan, Sharmiladevi Ramamoorthy, Guru Prasad Kuppuswamy, et al.
International Journal of Biological Macromolecules (2021) Vol. 193, pp. 1165-1200
Open Access | Times Cited: 22
Role of Diet and Nutrients in SARS-CoV-2 Infection: Incidence on Oxidative Stress, Inflammatory Status and Viral Production
Fatiha Brahmi, Anne Véjux, Imen Ghzaiel, et al.
Nutrients (2022) Vol. 14, Iss. 11, pp. 2194-2194
Open Access | Times Cited: 15
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
Isabel Leroux‐Roels, Cathy Maes, Jasper Joye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model
Balamurugan Shanmugaraj, Narach Khorattanakulchai, Weena Paungpin, et al.
Biotechnology Reports (2022) Vol. 37, pp. e00779-e00779
Open Access | Times Cited: 10
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses
Srividhya Venkataraman
Vaccines (2022) Vol. 10, Iss. 11, pp. 1805-1805
Open Access | Times Cited: 9
SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants
Tarlan Mamedov, Damla Yuksel, İrem Gürbüzaslan, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 4
A comprehensive review on efficient approaches for combating coronaviruses
Mahdi Pouresmaieli, Elena Ekrami, Ali Akbari, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112353-112353
Open Access | Times Cited: 8
Plant-Based Vaccines Against COVID-19 for Massive Vaccination in Africa
Islam El Jaddaoui, Najib Al Idrissi, Salsabil Hamdi, et al.
Frontiers in Drug Delivery (2022) Vol. 2
Open Access | Times Cited: 5
Plant-Produced S1 Subunit Protein of SARS-CoV-2 Elicits Immunogenic Responses in Mice
Chalisa Panapitakkul, Narach Khorattanakulchai, Kaewta Rattanapisit, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1961-1961
Open Access | Times Cited: 5
Global Innovation Trends for Plant-Based Vaccines Production: A Patent Analysis
Dario G. Frisio, Vera Ventura
Plants (2021) Vol. 10, Iss. 12, pp. 2558-2558
Open Access | Times Cited: 6
Production Technologies for Recombinant Antibodies: Insights into Eukaryotic, Prokaryotic, and Transgenic Expression Systems
Muhammad Saleem, Ghulam Zahra Jahangir, Ammara Saleem, et al.
Biochemical Genetics (2024)
Closed Access
Plant Molecular Pharming: A Promising Solution for COVID-19
Maribanyana Lebeko, Tamlyn M. Shaw, Sandra Jordaan, et al.
Concepts and strategies in plant sciences (2023), pp. 323-348
Closed Access | Times Cited: 1
Antiviral Phytocompounds Against Animal-to-Human Transmittable SARS-CoV-2
Partha Biswas, Anwar Parvez, Asif Abdullah, et al.
(2023), pp. 189-224
Closed Access
The Race to Manufacture COVID-19 Vaccines: Emerging Vaccine Technologies

(2023)
Open Access
Vacunas basadas en plantas. Nuevos desarrollos y oportunidades emergentes
Andrea Aguilar González, Araxie Bernadette Molina Monteleón, Ariana Ramírez Rodríguez
Deleted Journal (2022), Iss. 22, pp. 61-77
Open Access
Page 1

Scroll to top